BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen P, Fang QX, Chen DB, Chen HS. Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(7): 673-683 [PMID: 34322196 DOI: 10.4251/wjgo.v13.i7.673]
URL: https://www.wjgnet.com/1948-5182/full/v13/i7/673.htm
Number Citing Articles
1
Ben L. Da, Aiwu Ruth He, Kirti Shetty, Kelly I. Suchman, Herbert Yu, Lawrence Lau, Linda L. Wong, Atoosa Rabiee, Richard L. Amdur, James M. Crawford, Sharon S. Fox, Gregory M. Grimaldi, Priya K. Shah, Jonathan Weinstein, David Bernstein, Sanjaya K. Satapathy, Nyasha Chambwe, Xiyan Xiang, Lopa Mishra. Pathogenesis to management of hepatocellular carcinomaGenes & Cancer 2022; 13: 72 doi: 10.18632/genesandcancer.226
2
Tzy Harn Chua, Lavisha S Punjabi, Li Yan Khor. Tissue Pathogens and Cancers: A Review of Commonly Seen Manifestations in Histo- and CytopathologyPathogens 2021; 10(11): 1410 doi: 10.3390/pathogens10111410
3
Pu Chen, Dongbo Chen, Dechao Bu, Jie Gao, Wanying Qin, Kangjian Deng, Liying Ren, Shaoping She, Wentao Xu, Yao Yang, Xingwang Xie, Weijia Liao, Hongsong Chen. Dominant neoantigen verification in hepatocellular carcinoma by a single-plasmid system coexpressing patient HLA and antigenJournal for ImmunoTherapy of Cancer 2023; 11(4): e006334 doi: 10.1136/jitc-2022-006334
4
Yi-Fei Li, Qiong-Qiong Hou, Shuang Zhao, Xiaoyan Chen, Min Tang, Lin Li. Identification of tumor-specific neoantigens and immune clusters of hepatocellular carcinoma for mRNA vaccine developmentJournal of Cancer Research and Clinical Oncology 2023; 149(2): 623 doi: 10.1007/s00432-022-04285-7
5
David Repáraz, Belén Aparicio, Diana Llopiz, Sandra Hervás-Stubbs, Pablo Sarobe. Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?International Journal of Molecular Sciences 2022; 23(4): 2022 doi: 10.3390/ijms23042022
6
Seokhwan Chung, Chan Mi Lee, Miqin Zhang. Advances in nanoparticle-based mRNA delivery for liver cancer and liver-associated infectious diseasesNanoscale Horizons 2023; 8(1): 10 doi: 10.1039/D2NH00289B
7
Jenni Viivi Linnea Niemi, Aleksandr V. Sokolov, Helgi B. Schiöth. Neoantigen Vaccines; Clinical Trials, Classes, Indications, Adjuvants and Combinatorial TreatmentsCancers 2022; 14(20): 5163 doi: 10.3390/cancers14205163
8
M. V. Dmitrieva, M. A. Baryshnikovа, O. L. Orlova, V. S. Kosorukov. Technological aspects of creating neopeptide vaccinesRussian Journal of Biotherapy 2022; 21(4): 10 doi: 10.17650/1726-9784-2022-21-4-10-21
9
Nadine Soliman, Ashish Saharia, Maen Abdelrahim, Ashton A. Connor. Molecular profiling in the management of hepatocellular carcinomaCurrent Opinion in Organ Transplantation 2024; 29(1): 10 doi: 10.1097/MOT.0000000000001124